Cargando…
Computational Protein Design for COVID-19 Research and Emerging Therapeutics
[Image: see text] As the world struggles with the ongoing COVID-19 pandemic, unprecedented obstacles have continuously been traversed as new SARS-CoV-2 variants continually emerge. Infectious disease outbreaks are unavoidable, but the knowledge gained from the successes and failures will help create...
Autores principales: | Kalita, Parismita, Tripathi, Timir, Padhi, Aditya K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042144/ https://www.ncbi.nlm.nih.gov/pubmed/37122454 http://dx.doi.org/10.1021/acscentsci.2c01513 |
Ejemplares similares
-
Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
por: Kalita, Parismita, et al.
Publicado: (2020) -
Corrigendum to “Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2” [Microbial Pathog. 145 (2020) 104236]
por: Kalita, Parismita, et al.
Publicado: (2021) -
An efficient protocol to enhance recombinant protein expression using ethanol in Escherichia coli
por: Chhetri, Gaurav, et al.
Publicado: (2015) -
Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation
por: Padhi, Aditya K., et al.
Publicado: (2021) -
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
por: Padhi, Aditya K., et al.
Publicado: (2022)